Verint Systems (VRNT) Stock Value Declined While Rgm Capital Upped Holding by $16.31 Million; Johnson & Johnson (JNJ) Shareholder Independent Franchise Partners Llp Cut Its Position by $6.26 Million

May 22, 2018 - By whatsonthorold

Johnson & Johnson (NYSE:JNJ) Logo

Independent Franchise Partners Llp decreased its stake in Johnson & Johnson (JNJ) by 0.7% based on its latest 2017Q4 regulatory filing with the SEC. Independent Franchise Partners Llp sold 45,063 shares as the company’s stock declined 9.21% with the market. The institutional investor held 6.38M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $891.85 million, down from 6.43M at the end of the previous reported quarter. Independent Franchise Partners Llp who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $329.69 billion market cap company. The stock decreased 0.65% or $0.8 during the last trading session, reaching $122.92. About 2.90 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since May 22, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Robert G. Moses increased its stake in Verint Systems Inc (VRNT) by 25.55% based on its latest 2017Q4 regulatory filing with the SEC. Rgm Capital Llc bought 397,800 shares as the company’s stock declined 9.93% with the market. The hedge fund run by Robert G. Moses held 1.95M shares of the edp services company at the end of 2017Q4, valued at $81.80M, up from 1.56 million at the end of the previous reported quarter. Rgm Capital Llc who had been investing in Verint Systems Inc for a number of months, seems to be bullish on the $2.70B market cap company. The stock decreased 0.59% or $0.25 during the last trading session, reaching $42.15. About 67,958 shares traded. Verint Systems Inc. (NASDAQ:VRNT) has declined 5.87% since May 22, 2017 and is downtrending. It has underperformed by 17.42% the S&P500.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 101 analyst reports since August 7, 2015 according to SRatingsIntel. Jefferies maintained the shares of JNJ in report on Wednesday, October 18 with “Buy” rating. Societe Generale initiated Johnson & Johnson (NYSE:JNJ) on Wednesday, April 6 with “Hold” rating. RBC Capital Markets maintained it with “Buy” rating and $144.0 target in Friday, September 22 report. BMO Capital Markets maintained it with “Buy” rating and $13200 target in Friday, June 2 report. The firm has “Hold” rating given on Monday, October 2 by Piper Jaffray. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Wednesday, April 20 by Goldman Sachs. Credit Suisse maintained Johnson & Johnson (NYSE:JNJ) on Friday, April 20 with “Outperform” rating. The firm has “Buy” rating by BMO Capital Markets given on Tuesday, October 17. Leerink Swann maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, October 18. Leerink Swann has “Buy” rating and $165.0 target. As per Tuesday, July 18, the company rating was maintained by Stifel Nicolaus.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.05 earnings per share, up 12.02% or $0.22 from last year’s $1.83 per share. JNJ’s profit will be $5.50 billion for 14.99 P/E if the $2.05 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -0.49% negative EPS growth.

Independent Franchise Partners Llp, which manages about $13.30B and $11.79 billion US Long portfolio, upped its stake in S&P Global Inc by 57,846 shares to 3.83M shares, valued at $648.36M in 2017Q4, according to the filing. It also increased its holding in News Corp New (NASDAQ:NWS) by 79,175 shares in the quarter, for a total of 1.53M shares, and has risen its stake in Mondelez Intl Inc (NASDAQ:MDLZ).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Should The FDA Be Shaming Drug Companies? Financial Advisors’ Daily Digest” on May 21, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Presents at UBS Health Care Brokers Conference (Transcript)” published on May 21, 2018, Seekingalpha.com published: “Johnson & Johnson: Waiting On The Wave” on May 11, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Livetradingnews.com and their article: “Johnson & Johnson (NYSE:JNJ) Heffx Stock Technicals” published on May 18, 2018 as well as Fool.com‘s news article titled: “Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)” with publication date: May 02, 2018.

Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.04, from 0.83 in 2017Q3. It improved, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Private Trust Na holds 1.51% or 51,152 shares. Madrona Svcs holds 0.31% or 2,643 shares. Marble Harbor Counsel Ltd Liability Corporation, Massachusetts-based fund reported 55,007 shares. Private Asset Management Incorporated holds 112,586 shares. Ahl Prtn Ltd Liability Partnership has invested 0.11% in Johnson & Johnson (NYSE:JNJ). Richard C Young & holds 1.89% or 71,830 shares. M&R Management Inc accumulated 2.09% or 64,508 shares. Quantres Asset Management owns 0.62% invested in Johnson & Johnson (NYSE:JNJ) for 7,100 shares. Moreover, Dean Invest Associate Limited Liability Corp has 1.13% invested in Johnson & Johnson (NYSE:JNJ) for 52,764 shares. Cap Mgmt Associates New York holds 2,100 shares. Tompkins Fincl Corp reported 46,615 shares. Grandfield & Dodd Llc owns 1.58% invested in Johnson & Johnson (NYSE:JNJ) for 105,676 shares. Boyar Asset reported 22,474 shares. 7.90 million are held by New York State Common Retirement Fund. Bell Comml Bank has invested 0.12% in Johnson & Johnson (NYSE:JNJ).

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity.

Rgm Capital Llc, which manages about $775.24 million and $1.08B US Long portfolio, decreased its stake in Comscore Inc (NASDAQ:SCOR) by 200,304 shares to 2.56 million shares, valued at $72.87 million in 2017Q4, according to the filing. It also reduced its holding in Model N Inc (NYSE:MODN) by 641,985 shares in the quarter, leaving it with 655,683 shares, and cut its stake in Entegris Inc (NASDAQ:ENTG).

Investors sentiment decreased to 1.22 in 2017 Q4. Its down 0.25, from 1.47 in 2017Q3. It worsened, as 32 investors sold VRNT shares while 57 reduced holdings. 33 funds opened positions while 76 raised stakes. 59.15 million shares or 3.05% more from 57.40 million shares in 2017Q3 were reported. Convergence Inv Prtnrs Lc has invested 0.18% in Verint Systems Inc. (NASDAQ:VRNT). Impax Asset Mgmt Limited Liability owns 1.01% invested in Verint Systems Inc. (NASDAQ:VRNT) for 420,000 shares. 5.27 million are owned by Blackrock. Citadel Advisors Ltd Company invested in 0.01% or 204,904 shares. Creative Planning has 0% invested in Verint Systems Inc. (NASDAQ:VRNT) for 7,893 shares. Cubist Systematic Strategies Lc reported 8,133 shares. Eulav Asset Mngmt stated it has 16,500 shares. Panagora Asset Management Incorporated accumulated 104,992 shares. Cornercap Inv Counsel has invested 0.11% in Verint Systems Inc. (NASDAQ:VRNT). Macquarie Gp Ltd invested in 0% or 1,000 shares. Moors & Cabot Incorporated accumulated 0.04% or 7,050 shares. 27,100 were accumulated by Cornerstone Capital Management Hldgs Ltd Limited Liability Company. Strs Ohio has 3,900 shares. Cs Mckee LP holds 0.09% in Verint Systems Inc. (NASDAQ:VRNT) or 28,650 shares. Pnc Financial Services Gp has invested 0% in Verint Systems Inc. (NASDAQ:VRNT).

More important recent Verint Systems Inc. (NASDAQ:VRNT) news were published by: Businesswire.com which released: “Verint Names AARP “Customer Engagement Excellence Overall Winner” from Its Engage 2018 Global Customer …” on May 17, 2018, also Businesswire.com published article titled: “Verint Industry-Leading Workforce Engagement Solutions Guide Employee Actions in the Delivery of Smarter, Faster …”, Nasdaq.com published: “Consolidated Research: 2018 Summary Expectations for Verint, Mesabi Trust, Clearwater Paper, Agile Therapeutics …” on May 18, 2018. More interesting news about Verint Systems Inc. (NASDAQ:VRNT) was released by: Businesswire.com and their article: “Countdown to Next Week’s Verint Engage Conference in Dallas” with publication date: May 10, 2018.

Among 9 analysts covering Verint Systems (NASDAQ:VRNT), 6 have Buy rating, 1 Sell and 2 Hold. Therefore 67% are positive. Verint Systems had 33 analyst reports since September 3, 2015 according to SRatingsIntel. The stock of Verint Systems Inc. (NASDAQ:VRNT) has “Underperform” rating given on Wednesday, March 30 by Credit Suisse. The stock has “Outperform” rating by FBR Capital on Thursday, December 3. The stock of Verint Systems Inc. (NASDAQ:VRNT) has “Overweight” rating given on Wednesday, March 30 by JP Morgan. On Friday, June 9 the stock rating was maintained by Imperial Capital with “Hold”. Oppenheimer maintained the shares of VRNT in report on Thursday, September 3 with “Outperform” rating. The rating was upgraded by William Blair on Tuesday, September 29 to “Outperform”. The company was maintained on Thursday, May 17 by Oppenheimer. RBC Capital Markets maintained the stock with “Buy” rating in Thursday, June 8 report. RBC Capital Markets maintained Verint Systems Inc. (NASDAQ:VRNT) on Thursday, March 29 with “Buy” rating. The stock has “Hold” rating by William Blair on Sunday, September 6.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>